BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30767810)

  • 21. Surface disinfection challenges for Candida auris: an in-vitro study.
    Kean R; Sherry L; Townsend E; McKloud E; Short B; Akinbobola A; Mackay WG; Williams C; Jones BL; Ramage G
    J Hosp Infect; 2018 Apr; 98(4):433-436. PubMed ID: 29203448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast.
    Tsay S; Kallen A; Jackson BR; Chiller TM; Vallabhaneni S
    Clin Infect Dis; 2018 Jan; 66(2):306-311. PubMed ID: 29020224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The laboratory investigation, management, and infection prevention and control of
    Jones CR; Neill C; Borman AM; Budd EL; Cummins M; Fry C; Guy RL; Jeffery K; Johnson EM; Manuel R; Mirfenderesky M; Moore G; Patel B; Schelenz S; Staniforth K; Taori SK; Brown CS
    J Med Microbiol; 2024 May; 73(5):. PubMed ID: 38771623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Candida auris: estrategias y retos para prevenir un brote].
    Zuluaga-Rodríguez A
    Biomedica; 2020 Mar; 40(1):5-10. PubMed ID: 32220157
    [No Abstract]   [Full Text] [Related]  

  • 25. Are we ready for the global emergence of multidrug-resistant Candida auris in Taiwan?
    Lu PL; Liu WL; Lo HJ; Wang FD; Ko WC; Hsueh PR; Ho MW; Liu CE; Chen YH; Chen YC; Chuang YC; Chang SC
    J Formos Med Assoc; 2018 Jun; 117(6):462-470. PubMed ID: 29122404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soaps and germicides as adjunct topical antimycotic agents on candida species implicated in vulvovaginal candidasis.
    Ogunshe AA; Omotoso OA; Akindele TM
    East Afr J Public Health; 2011 Jun; 8(2):112-8. PubMed ID: 22066296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First report of sporadic cases of Candida auris in Colombia.
    Parra-Giraldo CM; Valderrama SL; Cortes-Fraile G; Garzón JR; Ariza BE; Morio F; Linares-Linares MY; Ceballos-Garzón A; de la Hoz A; Hernandez C; Alvarez-Moreno C; Le Pape P
    Int J Infect Dis; 2018 Apr; 69():63-67. PubMed ID: 29421668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging Fungal Pathogen Candida auris Evades Neutrophil Attack.
    Johnson CJ; Davis JM; Huttenlocher A; Kernien JF; Nett JE
    mBio; 2018 Aug; 9(4):. PubMed ID: 30131360
    [No Abstract]   [Full Text] [Related]  

  • 29. Candida auris in Healthcare Facilities, New York, USA, 2013-2017.
    Adams E; Quinn M; Tsay S; Poirot E; Chaturvedi S; Southwick K; Greenko J; Fernandez R; Kallen A; Vallabhaneni S; Haley V; Hutton B; Blog D; Lutterloh E; Zucker H;
    Emerg Infect Dis; 2018 Oct; 24(10):1816-1824. PubMed ID: 30226155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative Resistance of the Emerging Fungal Pathogen Candida auris and Other Candida Species to Killing by Ultraviolet Light.
    Cadnum JL; Shaikh AA; Piedrahita CT; Jencson AL; Larkin EL; Ghannoum MA; Donskey CJ
    Infect Control Hosp Epidemiol; 2018 Jan; 39(1):94-96. PubMed ID: 29157326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence.
    Short B; Brown J; Delaney C; Sherry L; Williams C; Ramage G; Kean R
    J Hosp Infect; 2019 Sep; 103(1):92-96. PubMed ID: 31226270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sensitivity to disinfectants of Candid albicans strains isolated from the hospital environment].
    Tadeusiak B
    Rocz Panstw Zakl Hig; 1998; 49(1):73-86. PubMed ID: 9734234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris.
    Chesnay A; Bailly É; Desoubeaux G
    J Mycol Med; 2021 Dec; 31(4):101173. PubMed ID: 34271481
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Hennessee IP; Forsberg K; Beekmann SE; Polgreen PM; Gold JAW; Lyman M
    Infect Control Hosp Epidemiol; 2024 Jun; 45(6):766-769. PubMed ID: 38449379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin Metagenomic Sequence Analysis of Early Candida auris Outbreaks in U.S. Nursing Homes.
    Huang X; Welsh RM; Deming C; Proctor DM; Thomas PJ; ; Gussin GM; Huang SS; Kong HH; Bentz ML; Vallabhaneni S; Chiller T; Jackson BR; Forsberg K; Conlan S; Litvintseva AP; Segre JA
    mSphere; 2021 Aug; 6(4):e0028721. PubMed ID: 34346704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultraviolet-C mediated inactivation of Candida auris, a rapid emerging health threat.
    Koutras C; Wade RL
    Am J Infect Control; 2024 Jan; 52(1):133-135. PubMed ID: 37634826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Disinfectants Against Candida auris and Other Candida Species.
    Cadnum JL; Shaikh AA; Piedrahita CT; Sankar T; Jencson AL; Larkin EL; Ghannoum MA; Donskey CJ
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1240-1243. PubMed ID: 28793937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skin and hard surface disinfection against
    Omardien S; Teska P
    Front Med (Lausanne); 2024; 11():1312929. PubMed ID: 38384416
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance?
    Weber DJ; Rutala WA
    Infect Control Hosp Epidemiol; 2006 Oct; 27(10):1107-19. PubMed ID: 17006819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Candida auris Outbreak and Its Control in an Intensive Care Setting.
    Eyre DW; Sheppard AE; Madder H; Moir I; Moroney R; Quan TP; Griffiths D; George S; Butcher L; Morgan M; Newnham R; Sunderland M; Clarke T; Foster D; Hoffman P; Borman AM; Johnson EM; Moore G; Brown CS; Walker AS; Peto TEA; Crook DW; Jeffery KJM
    N Engl J Med; 2018 Oct; 379(14):1322-1331. PubMed ID: 30281988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.